International Journal of Oncology

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures.
pp. 205-220(16)
Authors: Schirrmacher; Jurianz; Roth; Griesbach; Bonifer; Zawatzky

Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
pp. 217-241(25)
Authors: Ellerhorst, J; Nguyen, T; Cooper, D N; Lotan, D; Lotan, R

Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1.
pp. 225-257(33)
Authors: Ellerhorst, J; Nguyen, T; Cooper, D N; Estrov, Y; Lotan, D; Lotan, R

Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: implications for adoptive cell therapy of cancer.
pp. 233-277(45)
Authors: Cesano, A; Wortman, J A; Pourdehnad, M; Visonneau, S; Mozley, D; Bhatnagar, A; Alavi, A; Santoli, D

Biodistribution of human MHC non-restricted TALL-104 killer cells in healthy and tumor bearing mice.
pp. 245-296(52)
Authors: Cesano, A; Visonneau, S; Tran, T; Santoli, D

Killing effects of 5-fluorouracil on human biliary tract cancer cell lines.
pp. 253-260(8)
Authors: Moon, Y; Todoroki, T; Ohno, T; Fukao, K; Little, J B

A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
pp. 259-322(64)
Authors: Sugamata, N; Koibuchi, Y; Iino, Y; Morishita, Y

Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
pp. 265-336(72)
Authors: Okuda, K; Tanaka, M; Kanazawa, N; Nagashima, J; Satomura, S; Kinoshita, H; Eriguchi, N; Aoyagi, S; Kojiro, M

A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin.
pp. 273-282(10)
Authors: Hahn, S M; Russo, A; Cook, J A; Mitchell, J B

Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
pp. 281-287(7)
Authors: Nakagawa, T; Seki, T; Shiro, T; Wakabayashi, M; Imamura, M; Itoh, T; Tamai, T; Nishimura, A; Yamashiki, N; Matsuzaki, K; Sakaida, N; Inoue, K; Okamura, A

Big but weak: how many pathogenic genes does human herpesvirus-8 need to cause Kaposi's sarcoma? (Review).
pp. 287-296(10)
Authors: Sturzl, M; Ensoli, B

Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
pp. 291-591(301)
Authors: Rao, V H; Singh, R K; Delimont, D C; Finnell, R H; Bridge, J A; Neff, J R; Garvin, B P; Pickering, D L; Sanger, W G; Buehler, B A; Schaefer, G B

Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
pp. 301-308(8)
Authors: Serra, M; Maurici, D; Scotlandi, K; Barbanti-Brodano, G; Manara, M C; Benini, S; Picci, P; Bertoni, F; Bacci, G; Sottili, S; Baldini, N

Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing.
pp. 309-322(14)
Authors: Junker, K; Werner, W; Mueller, C; Ebert, W; Schubert, J; Claussen, U

Characterization of purified cathepsin D from malignant human breast tissue.
pp. 315-324(10)
Authors: Bazel, S; Alhadeff, J A

Antitumor effect of electrochemotherapy on colorectal carcinoma in an orthotopic mouse model.
pp. 321-327(7)
Authors: Kuriyama, S; Kikukawa, M; Mitoro, A; Tsujinoue, H; Nakatani, T; Yamazaki, M; Yoshiji, H; Toyokawa, Y; Yoshikawa, M; Fukui, H

A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells.
pp. 327-362(36)
Authors: Sharif, T R; Sharif, M

Suppression of tumorigenicity of rat liver epithelial tumor cell lines by a putative human 11p11.2-p12 liver tumor suppressor locus.
pp. 337-383(47)
Authors: Mahon, M C; Driscoll, M P; Glover, W J; Borchert, K M; Kelleher, Z T; Smith, G J; Coleman, W B

Adjuvant chemotherapy and radiation therapy for elimination of residual microscopic non-small cell lung cancer.
pp. 347-398(52)
Authors: Wright, S E; Sicola, V R; Martinez, H; Thompson, E; Pratt, D

Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma.
pp. 353-362(10)
Authors: Shimoda, K; Mori, M; Shibuta, K; Banner, B F; Barnard, G F

Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cells.
pp. 361-367(7)
Authors: Cavalcanti, M; Jewett, A; Bonavida, B

Gains of the relative genomic content of erbB-1 and erbB-2 in prostate carcinoma and their association with metastasis.
pp. 367-438(72)
Authors: Schwartz, S; Caceres, C; Morote, J; De Torres, I; Rodriguez-Vallejo, J M; Gonzalez, J; Reventos, J

Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor.
pp. 373-453(81)
Authors: McLaughlin, P J; Zagon, I S; Skitzki, J

Small cell carcinoma of the uterine cervix: a clinicopathological review.
pp. 381-387(7)
Authors: Sykes, A J; Shanks, J H; Davidson, S E